Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.
Hicks RJ, Dromain C, de Herder WW, Costa FP, Deroose CM, Frilling A, Koumarianou A, Krenning EP, Raymond E, Bodei L, Sorbye H, Welin S, Wiedenmann B, Wild D, Howe JR, Yao J, O'Toole D, Sundin A, Prasad V. Hicks RJ, et al. Among authors: wild d. J Neuroendocrinol. 2022 Mar;34(3):e13040. doi: 10.1111/jne.13040. Epub 2021 Oct 20. J Neuroendocrinol. 2022. PMID: 34668262 Free PMC article. Review.
Molecular imaging for neuroendocrine tumours.
Antwi K, Nicolas G, Wild D, Christ E. Antwi K, et al. Among authors: wild d. Swiss Med Wkly. 2019 Mar 10;149:w20017. doi: 10.4414/smw.2019.20017. eCollection 2019 Feb 25. Swiss Med Wkly. 2019. PMID: 30852831 Free article. Review.
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C, Falconi M, Fani M, Fanti S, Hicks RJ, Kabasakal L, Kaltsas G, Lewington V, Minozzi S, Cinquini M, Öberg K, Oyen WJG, O'Toole D, Pavel M, Ruszniewski P, Scarpa A, Strosberg J, Sundin A, Taïeb D, Virgolini I, Wild D, Herrmann K, Yao J. Ambrosini V, et al. Among authors: wild d. Eur J Cancer. 2021 Mar;146:56-73. doi: 10.1016/j.ejca.2021.01.008. Epub 2021 Feb 12. Eur J Cancer. 2021. PMID: 33588146 Free PMC article. Review.
New Directions in Imaging Neuroendocrine Neoplasms.
Refardt J, Hofland J, Wild D, Christ E. Refardt J, et al. Among authors: wild d. Curr Oncol Rep. 2021 Nov 4;23(12):143. doi: 10.1007/s11912-021-01139-2. Curr Oncol Rep. 2021. PMID: 34735669 Free PMC article. Review.
Molecular Imaging of Neuroendocrine Neoplasms.
Refardt J, Hofland J, Wild D, Christ E. Refardt J, et al. Among authors: wild d. J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2662-e2670. doi: 10.1210/clinem/dgac207. J Clin Endocrinol Metab. 2022. PMID: 35380158 Review.
A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours.
Wild D, Grønbæk H, Navalkissoor S, Haug A, Nicolas GP, Pais B, Ansquer C, Beauregard JM, McEwan A, Lassmann M, Pennestri D, Volteau M, Lenzo NP, Hicks RJ. Wild D, et al. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):183-195. doi: 10.1007/s00259-023-06383-1. Epub 2023 Sep 18. Eur J Nucl Med Mol Imaging. 2023. PMID: 37721581 Free PMC article. Clinical Trial.
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.
Schürrle SB, Eberlein U, Ansquer C, Beauregard JM, Durand-Gasselin L, Grønbæk H, Haug A, Hicks RJ, Lenzo NP, Navalkissoor S, Nicolas GP, Pais B, Volteau M, Wild D, McEwan A, Lassmann M. Schürrle SB, et al. Among authors: wild d. Eur J Nucl Med Mol Imaging. 2024 Mar 26. doi: 10.1007/s00259-024-06682-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38528164
611 results